Axonics (AXNX) SEC Filings & 10K Form

$66.64
+0.17 (+0.26%)
(As of 04/24/2024 ET)

Recent Axonics SEC Filings

DateFilerForm TypeView
04/04/2024
6:55 AM
Axonics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
4:24 PM
Axonics (Filer)
Form DEFA14A
02/28/2024
3:05 PM
Axonics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
7:00 AM
Axonics (Filer)
Form DEFM14A
02/09/2024
7:35 AM
Axonics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/06/2024
7:19 PM
Axonics (Filer)
Form PREM14A
02/02/2024
4:59 PM
Axonics (Issuer)
COHEN RAYMOND W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:59 PM
Axonics (Issuer)
Keese Kari Leigh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:59 PM
Axonics (Issuer)
Ford Alfred J Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:59 PM
Axonics (Issuer)
Woock John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:59 PM
Axonics (Issuer)
Noblett Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
5:00 PM
Axonics (Issuer)
Sama Rinda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:00 PM
Axonics (Issuer)
Noblett Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:19 PM
Axonics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
4:19 PM
Axonics (Filer)
Form DEF 14A
01/08/2024
7:47 AM
Axonics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
6:17 PM
Axonics (Issuer)
Noblett Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
12:31 PM
Axonics (Subject)
Noblett Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
8:09 AM
Axonics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
10/30/2023
3:06 PM
Axonics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
7:04 PM
Axonics (Issuer)
Keese Kari Leigh (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/03/2023
6:37 PM
Axonics (Issuer)
Dearen Danny L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:32 PM
Axonics (Issuer)
Dearen Danny L. (Reporting)
Form 4/A
08/21/2023
4:59 PM
Axonics (Subject)
Jiang Guangqiang (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2023
4:30 PM
Axonics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2023
6:47 PM
Axonics (Issuer)
Ford Alfred J Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:08 PM
Axonics (Subject)
Ford Alfred J Jr (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2023
7:42 PM
Axonics (Issuer)
CARREL MICHAEL H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
7:01 PM
Axonics (Issuer)
Ford Alfred J Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
7:21 PM
Axonics (Issuer)
McNamara Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
7:21 PM
Axonics (Issuer)
CARREL MICHAEL H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
7:21 PM
Axonics (Issuer)
snyderman nancy lynn MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
7:21 PM
Axonics (Issuer)
Kiernan Jane E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
7:22 PM
Axonics (Issuer)
Demski David M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
7:22 PM
Axonics (Issuer)
Lopez Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
3:06 PM
Axonics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
7:01 PM
Axonics (Issuer)
Dearen Danny L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2023
7:06 PM
Axonics (Issuer)
Dearen Danny L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2023
7:35 PM
Axonics (Issuer)
Dearen Danny L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AXNX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners